Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C9orf24 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | PSMA5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | SCN3B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | NOP10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | STARD9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | GPBP1L1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | PROM1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | TANGO6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | RAPGEF5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ZCCHC18 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |